News
-
-
-
COMMUNIQUÉ DE PRESSE
Deadly Measles Cases Accentuate the Need for a Treatment - NV-387 is Here to Help Patients and Control Spread, Says NanoViricides
NanoViricides, Inc. comments on their drug candidate NV-387 as a weapon against measles outbreaks worldwide. The drug shows promise in treating patients and preventing transmission -
-
-
COMMUNIQUÉ DE PRESSE
Measles Rare Pediatric Disease Drug Designation Application Filed for NV-387, PRV Provides for Strong Business Case, Says NanoViricides
NanoViricides files RPDD application for NV-387 as Measles treatment with US FDA, potentially eligible for PRV upon approval. Addressing rising Measles cases, vaccination challenges -
-
-
-
